Abstract
In response to: Multiple assays in a real-time RT-PCR severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have